This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Albert-Ludwigs-Universitaet Freiburg. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Irina Kuckuck: Innovator in Chimeric Antigen Receptors
Introduction
Irina Kuckuck is a prominent inventor based in Freiburg, Germany. She has made significant contributions to the field of immunotherapy, particularly in the development of chimeric antigen receptors (CARs) that target prostate-specific membrane antigen (PSMA). Her innovative work aims to enhance the effectiveness of cancer treatments.
Latest Patents
Irina Kuckuck holds a patent for a novel chimeric antigen receptor that specifically binds to PSMA. This invention relates to a method of manufacturing high-quality CAR T cell products through transfection and/or transduction of T cells. The approach allows for effective in vivo tumor treatment, either alone or in combination with various pharmaceutical drugs, including chemotherapies and biopharmaceuticals.
Career Highlights
Irina is affiliated with the Albert-Ludwigs-Universität Freiburg, where she conducts her research and development work. Her dedication to advancing cancer therapies has positioned her as a key figure in the field of immunotherapy.
Collaborations
Irina collaborates with Toni Cathomen, a fellow researcher, to further explore the potential of CAR T cell therapies. Their partnership focuses on enhancing the efficacy of cancer treatments through innovative approaches.
Conclusion
Irina Kuckuck's contributions to the field of chimeric antigen receptors represent a significant advancement in cancer therapy. Her work continues to inspire future innovations in the treatment of tumors.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile